There are ongoing discussions at the WTO regarding the proposal to waive the patents on vaccinations and other Covid-related items, supposedly allowing production of more doses. This proposal was backed by the US last week, however it may not fully address the issue and is raising more concerns related to manufacturing, supply chain and quality. The EU and UK are more in favour of supply chain improvements, creating partnerships leading to voluntary licensing, such as collaborations between the Serum Institute of India and Oxford-AstraZeneca. Right now, the time to a full resolution of the epidemiological situation worldwide remains unclear. Undoubtedly, there will be further costs to the worldwide economy. While the UK vaccine rollout is expected to contribute to a boost of the UK economy in the near and medium term, and we hope to start moving towards the national recovery, it is important to keep in mind the global outlook and strengthen our international partnerships.
Advise . Educate . Innovate
The Aspen Waite team is working tirelessly to create new international collaborations. We are confident that our unique position would create significant synergies in healthcare, manufacturing, and other areas in the EU and beyond. References: 1. https://www.washingtonpost.com/world/ interactive/2021/coronavirus-vaccine-inequalityglobal/ 2. https://www.bbc.co.uk/news/world-56237778 3. https://fortune.com/2021/05/07/covidtreatment-at-home-pills-tamiflu-coronavirus/ 4. https://www.pfizer.com/news/press-release/ press-release-detail/pfizer-initiates-phase-1-studynovel-oral-antiviral 5. https://www.reuters.com/world/middle-east/ who-gives-emergency-approval-sinopharm-firstchinese-covid-19-vaccine-2021-05-07/
